Smith Nephew Snats Stock Today
| SNN Stock | USD 25.04 0.17 0.67% |
Performance0 of 100
| Odds Of DistressLess than 8
|
Smith Nephew is selling at 25.04 as of the 21st of November 2024; that is 0.67 percent decrease since the beginning of the trading day. The stock's open price was 25.21. Smith Nephew has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Smith Nephew SNATS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of December 2022 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of November 1999 | Category Healthcare | Classification Health Care |
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 435.99 M outstanding shares of which 2.43 M shares are at this time shorted by investors with about 3.22 days to cover. More on Smith Nephew SNATS
Moving together with Smith Stock
Moving against Smith Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Smith Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chief Executive Officer | Deepak Nath | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Obamacare Repeal (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Sanne Group plc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Bucharest BET-NG, Bucharest Total Return, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSmith Nephew can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Smith Nephew's financial leverage. It provides some insight into what part of Smith Nephew's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Smith Nephew SNATS (SNN) is traded on New York Stock Exchange in USA. It is located in Building 5, Watford, United Kingdom, WD18 8YE and employs 18,000 people. Smith Nephew is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 10.99 B. Smith Nephew SNATS runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 435.99 M outstanding shares of which 2.43 M shares are at this time shorted by investors with about 3.22 days to cover.
Smith Nephew SNATS has about 516 M in cash with 608 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18.
Check Smith Nephew Probability Of Bankruptcy
Ownership AllocationSmith Nephew SNATS shows a total of 435.99 Million outstanding shares. About 92.12 % of Smith Nephew outstanding shares are held by general public with 0.02 (%) owned by insiders and only 7.86 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Smith Ownership Details
Smith Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bmo Capital Markets Corp. | 2024-06-30 | 1.2 M | |
| Clark Estates Inc | 2024-09-30 | 685 K | |
| Balyasny Asset Management Llc | 2024-06-30 | 650.1 K | |
| Sio Capital Management, Llc | 2024-06-30 | 579.6 K | |
| Hsbc Holdings Plc | 2024-06-30 | 548.7 K | |
| Jane Street Group Llc | 2024-06-30 | 547.4 K | |
| Wells Fargo & Co | 2024-06-30 | 512.6 K | |
| Envestnet Asset Management Inc | 2024-06-30 | 485.5 K | |
| Heartland Advisors Inc | 2024-09-30 | 437.1 K | |
| Fiduciary Management, Inc. Of Milwaukee | 2024-06-30 | 4.4 M | |
| Barrow Hanley Mewhinney & Strauss Llc | 2024-09-30 | 3.9 M |
Smith Nephew Historical Income Statement
Smith Stock Against Markets
Smith Nephew Corporate Directors
| Bob White | Non-Executive Independent Director | Profile | |
| Erik Engstrom | Non-Executive Independent Director | Profile | |
| Marc Owen | Non-Executive Independent Director | Profile | |
| AnneFrancoise Nesmes | Chief Financial Officer, Executive Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.244 | Dividend Share 0.375 | Earnings Share 0.7 | Revenue Per Share 2.5904 | Quarterly Revenue Growth 0.034 |
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.